Philip Morris
Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
Fields
- Author
- Katzenstein, A.W.
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Characteristic
- EXTR, EXTRA
- Named Person
- Svendsen
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Author (Organization)
- Am J Epidemiol
- Site
- R529
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- ohc02a00
Document Images
LE7TERS TO THE EDITOR' 227
givenl. In this analysis, the 13 coronary heart disease
deaths imthe never smokers are again included and
the proportions to which they contribute are tested
for statistical significance three more times. The ap-
propriate analysis would have examined only the 2,222
ex-smokers in the same terms, as suggested for
table 7.
The reader who is interested in outcomes other
than coronary heart disease death is forced to use
guesswork to subtract this effect from the other data
in the tables. For example, even though we are not
told the numbers of men imtable 9, the much lower p
vahie for "death from any cause" than in table 7
suggests that this difference is due to the contribution
of the ex-smokers. Had'these been analyzed sepa-
rately, the difference in risk of "death from any cause"'
between the exposed and nonexposed ex-smokers
would probably have beem even more marked. This
would have suggested'that the men who stopped smok-
ing were especially susceptible to second-hand tobacco
smoke. A presentation of the data that did' not lump
and overlap the subsets of interest would have made
such speculation unnecessan.
The study by Svendsen et al. is presented as an
exploration without hyTothesis. This "blurred" anah-
sis could have been avoided if,this,repon had set out
to investigate an explicit hypothesis that specified the
target groupand the expected endpoint. Paradoxicalh,
focussing in on a specific research question and follow-
ing the method'appropriate to address that question
often allows the researchers to isolate and investigate
secondary or unexpected results more accurately.
RErERENCE
1. Svendnen K.H. Kuller LH, Manin Ma;.etal: Ettects of
passive smoking intheMuluple.Risk,Factor Intenrnttmn
Trial. Am J EpidemioV 19fiT.:126.'&3-95..
Peter Morgan
118:Mill'Street
Lanork, Ontario
Conada KOG 1X0
J
` / A ~
VRE: 'EFFECTS OF PASSIVE SMOKING IN THE MULTIRLE RISK FACTOR C1` l..-
'-
INTERVENTIQN' TRIAL"
7 c. . lkg'i ~.Z2
Svendsen et al. (l') analyze data from the Multiple
Risk Factor Intervention Trial (MRFITI'study and
report the relative risks of various endpoint events for
men who never smoked in relation to spousal smoking.
They assert that their data provide "further evidence
of a potential'serious health risk for a large segmentt
of the nonsmoking population" (1p. 792). This con-
clusion does not appear to be supported by the data
presented.
For morbidity and mortality, the relative risks are
noostatistically significant; except for the "all deaths"
category for the group combining 'never smoked" and
"ex-smoker" males. Since the relative risk for "coro-
nary heart disease deaths" was not significantly ele-
vated for that group, the increased relative risk for
`all deaths" requires some explenation before the sta-
tistics can be assumed to indicate a meaningful in-
crease in health risk related to spousal smoking.
While the statistics alone raise serious doubt about
the conclusion of increased health risk for nonsmokers
exposed to environmental tobacco smoke based on
spousal smoking, questions also need to be raised
about the quality of the evidence on w-hich the assess-
ments are based, notably the nonhomogeneity between
the groups based on spousal smoking classification.
The lack of homogeneity was implicit when adjust-
ments were made for differences in some coronary
hearo disease risk factorse.g., age, weight, blood pres-
sure, and alcohol consumption;,but there is no indi-
cation that the adjustment inclUded'consideration of
the additive effect of multiple risk factors, as has been
demonstrated in numerous other studies, notably the
Framingham Heart Study. There is no indication that
other coronary heart disease risk factors, e.g., familyy
history and exercisewere considered or adjusted for.
Differences in forced'expiratory volume in one second
(FEV,) among the groups were also cited. The numer,
ous confounding coronary heart disease risk factors
should not be disregarded& nor can statistical adjust
ments be made to eliminate their possible roles. Thus.
while the MRFIT'study was well designed to assess
the effect of various interventions according to se-
lected risk factors, it does not appear to have been
designed to assess the environmental tobacco smoke
exposure as a coronary heart disease risk factor.
Svendsen et al: observe that men whose wives
smoked had "significant1Y lower levels of pulmonan
function at baseline"' (1, p. 786). The authors fail;
however, to note and to interpret the data in table 6.
which shows FEV,,levels for men whose wives smoked
20+, cigarettes/day were markedly htFh'cr than those
of men whose wives smoked 1-19 cigarettes/day, both
at baseline and averaged over all visits. R'ithisuch a
notable reversal of the doseresponse relation; which
must be demonstrated! if causal inferenees are to be
supported, there seems to be little basis for suggesting
the possibility of' any relhtiom bet..een pulmonary
function and spousal smoking from this studi:
The weakness ofithe evidence thus raise~ imponant
questions about the conclitsion that `paai.e smokinF
is associated with an increase in morbiditv and mor-
tality, among nonsmokers" (1, p. 791)i There ic. cer-
tainly no convincing demonstration that spousal
smoking constitutes a"potential serious health riak"
for anyy segment of the nonsmoking popularion.
REFERF.r:CE'
1. CtYndsen KH. Kuller l:H,,\txnin Slll. ev sl EflrrtF of
pe~ivexmokinR in thr 1\tuhiple Hi,A FarvIr, lmet+ent.un
Triali Am J F.pidemiol 19++ i:1 L'h. S r:'i- p5:
Alan 11'. }Catzenstein
ltiSotZCrtsatctn r1s.-uCrOtPs.
57 Ruckuuod I)rinr
Larchmctn/, .^''V 1033t;
